172 related articles for article (PubMed ID: 9703171)
1. Humoral and cellular immune parameters before and during immunosuppressive therapy of a patient with stiff-man syndrome and insulin dependent diabetes mellitus.
Hummel M; Durinovic-Bello I; Bonifacio E; Lampasona V; Endl J; Fessele S; Then Bergh F; Trenkwalder C; Standl E; Ziegler AG
J Neurol Neurosurg Psychiatry; 1998 Aug; 65(2):204-8. PubMed ID: 9703171
[TBL] [Abstract][Full Text] [Related]
2. Antibodies to the tyrosine phosphatase-like protein IA-2 are highly associated with IDDM, but not with autoimmune endocrine diseases or stiff man syndrome.
Morgenthaler NG; Seissler J; Achenbach P; Glawe D; Payton M; Meinck HM; Christie MR; Scherbaum WA
Autoimmunity; 1997; 25(4):203-11. PubMed ID: 9344328
[TBL] [Abstract][Full Text] [Related]
3. Glutamic acid decarboxylase autoantibodies in stiff-man syndrome and insulin-dependent diabetes mellitus exhibit similarities and differences in epitope recognition.
Daw K; Ujihara N; Atkinson M; Powers AC
J Immunol; 1996 Jan; 156(2):818-25. PubMed ID: 8543838
[TBL] [Abstract][Full Text] [Related]
4. Humoral immunity against glutamic acid decarboxylase and tyrosine phosphatase IA-2 in Lambert-Eaton myasthenic syndrome.
Hermitte L; Martin-Moutot N; Boucraut J; Barone R; Atlan-Gepner C; Seagar M; Pouget J; Kleisbauer JP; Couraud F; Vialettes B
J Clin Immunol; 2000 Jul; 20(4):287-93. PubMed ID: 10939716
[TBL] [Abstract][Full Text] [Related]
5. High T cell responses to the glutamic acid decarboxylase (GAD) isoform 67 reflect a hyperimmune state that precedes the onset of insulin-dependent diabetes.
Honeyman MC; Stone N; de Aizpurua H; Rowley MJ; Harrison LC
J Autoimmun; 1997 Apr; 10(2):165-73. PubMed ID: 9185878
[TBL] [Abstract][Full Text] [Related]
6. A monoclonal antibody-based characterization of autoantibodies against glutamic acid decarboxylase in adults with latent autoimmune diabetes.
Ziegler B; Strebelow M; Rjasanowski I; Schlosser M; Ziegler M
Autoimmunity; 1998; 28(2):61-8. PubMed ID: 9771977
[TBL] [Abstract][Full Text] [Related]
7. Higher autoantibody levels and recognition of a linear NH2-terminal epitope in the autoantigen GAD65, distinguish stiff-man syndrome from insulin-dependent diabetes mellitus.
Kim J; Namchuk M; Bugawan T; Fu Q; Jaffe M; Shi Y; Aanstoot HJ; Turck CW; Erlich H; Lennon V; Baekkeskov S
J Exp Med; 1994 Aug; 180(2):595-606. PubMed ID: 7519242
[TBL] [Abstract][Full Text] [Related]
8. Murine monoclonal glutamic acid decarboxylase (GAD)65 antibodies recognize autoimmune-associated GAD epitope regions targeted in patients with type 1 diabetes mellitus and stiff-man syndrome.
Ziegler B; Schlosser M; Lühder F; Strebelow M; Augstein P; Northemann W; Powers AC; Ziegler M
Acta Diabetol; 1996 Sep; 33(3):225-31. PubMed ID: 8904930
[TBL] [Abstract][Full Text] [Related]
9. Immune reactivity to glutamic acid decarboxylase 65 in stiffman syndrome and type 1 diabetes mellitus.
Lohmann T; Hawa M; Leslie RD; Lane R; Picard J; Londei M
Lancet; 2000 Jul; 356(9223):31-5. PubMed ID: 10892762
[TBL] [Abstract][Full Text] [Related]
10. GAD65-Reactive T cells in a non-diabetic stiff-man syndrome patient.
Schloot NC; Batstra MC; Duinkerken G; De Vries RR; Dyrberg T; Chaudhuri A; Behan PO; Roep BO
J Autoimmun; 1999 Jun; 12(4):289-96. PubMed ID: 10330300
[TBL] [Abstract][Full Text] [Related]
11. GAD autoantibodies in IDDM, stiff-man syndrome, and autoimmune polyendocrine syndrome type I recognize different epitopes.
Björk E; Velloso LA; Kämpe O; Karlsson FA
Diabetes; 1994 Jan; 43(1):161-5. PubMed ID: 7505244
[TBL] [Abstract][Full Text] [Related]
12. [IA-2 and anti-GAD antibodies in patients with newly diagnosed type 1 diabetes and their first degree relatives].
Kretowski A; Kowalska I; Peczyńska J; Urban M; Kinalska I
Przegl Lek; 2000; 57(3):143-6. PubMed ID: 10909282
[TBL] [Abstract][Full Text] [Related]
13. T-cell reactivity to glutamic acid decarboxylase in stiff-man syndrome and cerebellar ataxia associated with polyendocrine autoimmunity.
Costa M; Saiz A; Casamitjana R; Castañer MF; Sanmartí A; Graus F; Jaraquemada D
Clin Exp Immunol; 2002 Sep; 129(3):471-8. PubMed ID: 12197888
[TBL] [Abstract][Full Text] [Related]
14. The insulin-dependent diabetes mellitus-associated ICA 105 autoantigen in stiff-man syndrome patients.
Martino G; Grimaldi LM; Bazzigaluppi E; Passini N; Sinigaglia F; Rogge L
J Neuroimmunol; 1996 Sep; 69(1-2):129-34. PubMed ID: 8823384
[TBL] [Abstract][Full Text] [Related]
15. Autoimmunity to glutamic acid decarboxylase in the neurodegenerative disorder Batten disease.
Ramirez-Montealegre D; Chattopadhyay S; Curran TM; Wasserfall C; Pritchard L; Schatz D; Petitto J; Hopkins D; She JX; Rothberg PG; Atkinson M; Pearce DA
Neurology; 2005 Feb; 64(4):743-5. PubMed ID: 15728308
[TBL] [Abstract][Full Text] [Related]
16. Characterization of antibody responses to endogenous and exogenous antigen in the nonobese diabetic mouse.
Koczwara K; Schenker M; Schmid S; Kredel K; Ziegler AG; Bonifacio E
Clin Immunol; 2003 Feb; 106(2):155-62. PubMed ID: 12672406
[TBL] [Abstract][Full Text] [Related]
17. Antibodies to GAD65 and a tyrosine phosphatase-like molecule IA-2ic in Filipino type 1 diabetic patients.
Medici F; Hawa MI; Giorgini A; Panelo A; Solfelix CM; Leslie RD; Pozzilli P
Diabetes Care; 1999 Sep; 22(9):1458-61. PubMed ID: 10480509
[TBL] [Abstract][Full Text] [Related]
18. Heterogeneity in the occurrence of a subset of autoantibodies to glutamic acid decarboxylase in autoimmune polyendocrine patients with islet cell antibodies.
Davenport C; Radford PM; Al-Bukhari TA; Lai M; Bottazzo GF; Todd I
Clin Exp Immunol; 1998 Mar; 111(3):497-505. PubMed ID: 9528889
[TBL] [Abstract][Full Text] [Related]
19. Absence of avidity maturation of autoantibodies to the protein tyrosine phosphatase-like IA-2 molecule and glutamic acid decarboxylase (GAD65) during progression to type 1 diabetes.
Westerlund A; Ankelo M; Ilonen J; Knip M; Simell O; Hinkkanen AE
J Autoimmun; 2005 Mar; 24(2):153-67. PubMed ID: 15829408
[TBL] [Abstract][Full Text] [Related]
20. Diminished IFN-gamma response to diabetes-associated autoantigens in children at diagnosis and during follow up of type 1 diabetes.
Faresjö MK; Vaarala O; Thuswaldner S; Ilonen J; Hinkkanen A; Ludvigsson J
Diabetes Metab Res Rev; 2006; 22(6):462-70. PubMed ID: 16572494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
